Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Receivables - Other (2016 - 2026)

Usana Health Sciences has reported Receivables - Other over the past 12 years, most recently at $8.1 million for Q1 2026.

  • Quarterly Receivables - Other changed N/A to $8.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Jan 2026, changed N/A year-over-year, with the annual reading at $8.1 million for FY2026, N/A changed from the prior year.
  • Receivables - Other was $8.1 million for Q1 2026 at Usana Health Sciences, up from $6.2 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $8.1 million in Q1 2026 and troughed at $5.6 million in Q1 2022.
  • The 3-year median for Receivables - Other is $6.2 million (2023), against an average of $6.6 million.
  • The largest YoY upside for Receivables - Other was 10.68% in 2022 against a maximum downside of 10.68% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $5.6 million in 2022, then rose by 10.53% to $6.2 million in 2023, then skyrocketed by 31.06% to $8.1 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Receivables - Other are $8.1 million (Q1 2026), $6.2 million (Q4 2023), and $5.6 million (Q1 2022).